Company
Amgen
651 Legal Matters
60
470
121

Amgen Company IP Overview

Practice Areas
Recent StatisticsView All
Subscription-Only
View Concierge Program
PatentsView All
Patents Issued Each Year
TrademarksView All
Trademark Applications Filed Each Year
LitigationView All
Cases Filed Each Year
Mikele Bicolli
US Supreme Court's Ruling in Amgen v Sanofi Sets Precedent for Patent Enablement
Mikele Bicolli
May 19, 2023
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal... Read More
Mikele Bicolli
The U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody Patent Case
Mikele Bicolli
Nov 9, 2022
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought... Read More
Pedram Sameni
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni
Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More
Practice Areas
PatentsView All
Patents Issued Each Year
LitigationView All
Cases Filed Each Year
Recent StatisticsView All
Subscription-Only
View Concierge Program
TrademarksView All
Trademark Applications Filed Each Year
Mikele Bicolli
US Supreme Court's Ruling in Amgen v Sanofi Sets Precedent for Patent Enablement
Mikele Bicolli
May 19, 2023
The recent judgment in Amgen v Sanofi by the United States Supreme Court has generated significant attention within the legal... Read More
Mikele Bicolli
The U.S. Supreme Court is About to Ultimately Decide Amgen vs Sanofi Antibody Patent Case
Mikele Bicolli
Nov 9, 2022
Most of the community involved in life science litigation and pharmaceutical companies, thought they saw the end of the long-fought... Read More
Pedram Sameni
Patexia Insight 157: Most Active Companies in Biosimilar Litigation (BPCIA Act)
Pedram Sameni
Nov 3, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More